First Line Gefitinib by FDG-PET Metabolic Response

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2013 by Asan Medical Center
Sponsor:
Collaborator:
AstraZeneca
Information provided by (Responsible Party):
Sang-We Kim, Asan Medical Center
ClinicalTrials.gov Identifier:
NCT01510990
First received: January 10, 2012
Last updated: January 26, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: November 2015
  Estimated Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)